Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 75/100

BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next...

Key Takeaway: Becton, Dickinson and Company (BD) announced the upcoming installment of its BD Innovates series, focusing on its Pharmaceutical Systems business. Scheduled for December 11, 2023, this presentation aligns with BD's 2025 Strategy aimed at promoting innovation and product development. The event will be streamed live, and a replay will be accessible afterward, underscoring the company's emphasis on stakeholder engagement and transparency.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD is showcasing its commitment to innovation through the BD Innovates series.
  • The event aims to highlight the Pharmaceutical Systems business, suggesting a focus on important healthcare areas.
  • Live webcasting and replay availability enhance accessibility for stakeholders.

Full Press Release Details

FRANKLIN LAKES, N.J. , Dec. 4, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will highlight its Pharmaceutical Systems business on Monday, December 11, 2023 , at 11:30 am Eastern Time . The BD Innovates series spotlights BD's innovation, products and pipeline in support of its BD 2025 Strategy.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and on X (formerly known as Twitter) @BDandCo .
Contacts:
Media : Investors :
Troy Kirkpatrick Adam Reiffe
VP, Public Relations Sr. Director, Investor Relations
858.617.2361 201.847.6927
[email protected] [email protected]
SOURCE BD (Becton, Dickinson and Company)

21 %

Frequently Asked Questions

When will the next BD Innovates series be held?

The next BD Innovates series is on December 11, 2023, at 11:30 am ET.

Where can I watch the BD Innovates presentation?

The presentation can be viewed on the BD investor relations website.

What does BD focus on in its Pharmaceutical Systems business?

BD focuses on innovation, products, and pipeline in the Pharmaceutical Systems sector.

How many employees does BD have globally?

BD employs over 70,000 people worldwide.

What is BD's primary goal?

BD aims to improve health care delivery for patients and providers.

Last updated: Dec 4, 2023